126 related articles for article (PubMed ID: 26463467)
1. Relapse Pattern and Treatment Outcome of Curative Radiotherapy for Primary Cutaneous CD30+ Anaplastic Large-cell Lymphoma: A Retrospective Cohort Study.
Huang BS; Chen WY; Wang CW; Cheng AL; Hong JH; Kuo SH
Acta Derm Venereol; 2016 Mar; 96(3):394-5. PubMed ID: 26463467
[No Abstract] [Full Text] [Related]
2. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
3. Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy.
Yu JB; McNiff JM; Lund MW; Wilson LD
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1542-5. PubMed ID: 18037577
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.
Melchers RC; Willemze R; Daniëls LA; Neelis KJ; Bekkenk MW; de Haas ERM; Horvath B; van Rossum MM; Sanders CJG; Velstra B; Veraart JCJM; Roach REJ; Vermeer MH; Quint KD
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1279-1285. PubMed ID: 28958772
[TBL] [Abstract][Full Text] [Related]
5. Congenital primary cutaneous anaplastic large-cell lymphoma: a case report.
Seo AN; Lee SJ; Choi YH; Chung HY; Huh J; Yoon GS
Am J Dermatopathol; 2015 May; 37(5):398-400. PubMed ID: 25365497
[TBL] [Abstract][Full Text] [Related]
6. Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders.
Ferrara G; Ena L; Cota C; Cerroni L
Am J Surg Pathol; 2015 Nov; 39(11):1511-7. PubMed ID: 26371781
[TBL] [Abstract][Full Text] [Related]
7. Complete remission of refractory, ulcerated, primary cutaneous CD30+ anaplastic large cell lymphoma following brentuximab vedotin therapy.
Patsinakidis N; Kreuter A; Moritz RK; Stücker M; Altmeyer P; Möllenhoff K
Acta Derm Venereol; 2015 Feb; 95(2):233-4. PubMed ID: 24733422
[No Abstract] [Full Text] [Related]
8. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases.
Kong YY; Dai B; Kong JC; Lu HF; Shi DR
Histopathology; 2009 Aug; 55(2):189-96. PubMed ID: 19694826
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous anaplastic large-cell lymphoma.
Newlove T; Loyd A; Patel R; Jelinek J; Latkowski JA
Dermatol Online J; 2010 Nov; 16(11):2. PubMed ID: 21163153
[TBL] [Abstract][Full Text] [Related]
10. ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
Geller S; Canavan TN; Pulitzer M; Moskowitz AJ; Myskowski PL
Int J Dermatol; 2018 May; 57(5):515-520. PubMed ID: 29057463
[TBL] [Abstract][Full Text] [Related]
11. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.
Duvic M; Tetzlaff MT; Gangar P; Clos AL; Sui D; Talpur R
J Clin Oncol; 2015 Nov; 33(32):3759-65. PubMed ID: 26261247
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic large-cell T-cell lymphoma.
Stein JA; Soldano AC; Latkowski JA
Dermatol Online J; 2008 May; 14(5):15. PubMed ID: 18627751
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous CD30-positive anaplastic large cell lymphoma in a 16-year-old girl.
Kocabaş E; Türel Ermertcan A; Akinci S; Temiz P; Gündüz K
Int J Dermatol; 2012 Nov; 51(11):1353-8. PubMed ID: 21972869
[No Abstract] [Full Text] [Related]
14. Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site.
Lee WJ; Moon IJ; Lee SH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2016 Jun; 74(6):1135-43. PubMed ID: 26897385
[TBL] [Abstract][Full Text] [Related]
15. Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder.
Saini S; Dettore AJ; Bhambhani KJ; Buck S; Poulik J; Savaşan S
J Pediatr Hematol Oncol; 2011 May; 33(4):e156-9. PubMed ID: 21516014
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy of primary cutaneous anaplastic large cell lymphoma: our experience in 30 cases.
Piccinno R; Damiani G; Rossi LC; Berti E
Int J Dermatol; 2020 Apr; 59(4):469-473. PubMed ID: 31916593
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous anaplastic large cell lymphoma with angioinvasive features and cytotoxic phenotype: a rare lymphoma variant within the spectrum of CD30+ lymphoproliferative disorders.
Kempf W; Kazakov DV; Paredes BE; Laeng HR; Palmedo G; Kutzner H
Dermatology; 2013; 227(4):346-52. PubMed ID: 24246691
[TBL] [Abstract][Full Text] [Related]
18. A case report of aggressive course of CD30+ primary cutaneous anaplastic large cell lymphoma.
Lyu WT; Song QB; Qiong W; Liu J; Yong R; Yi FT; Han DL
Medicine (Baltimore); 2021 May; 100(18):e25770. PubMed ID: 33950967
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic large cell lymphoma of scrotal skin.
Mehdi I; Praseeda I; Al-Bahrani BJ; Satayapal N; Monem AA; Al Kharusi S
J Pak Med Assoc; 2011 Nov; 61(11):1140-3. PubMed ID: 22126000
[TBL] [Abstract][Full Text] [Related]
20. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
McKelvie PA; Thompson PA; Tam CS
Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
